Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron Overload

Clinical trial NCT01459718 · TERMINATED

Trial details

NCT number: NCT01459718
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Transfusion-dependent β-thalassemia Patients Cardiac Iron Overload

Start date: 2011-01-01
Primary completion: 2014-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.